Sangamo Therapeutics GAAP EPS of -$0.11 misses by $0.11, revenue of $0.6M misses by $33.8M (NASDAQ:SGMO)
Sangamo TherapeuticsSangamo Therapeutics(US:SGMO) Seeking Alpha·2025-11-06 13:06

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]